Table 1 Demographics and baseline characteristics of COVID-19 patients
From: Beware of pharyngeal Fusobacterium nucleatum in COVID-19
|  | Pharyngeal swab samples (n = 28) | Fecal samples (n = 36) |
|---|---|---|
Age (yrs) - medium (IQR) | 36.0 (28 ~ 49.5) | 46.5 (34.3 ~ 56.0) |
Age groups – No. (%) | ||
  ≤ 30 yrs | 11 (39.29) | 8 (22.22) |
 31 ~ 50 yrs | 10 (35.71) | 15 (41.67) |
 >50 yrs | 7 (25.00) | 13 (36.11) |
Sex – No. (%) | ||
 Male | 20 (71.43) | 18 (50) |
 Female | 8 (28.67) | 18 (50) |
Severity of illness – No. (%) | ||
 Asymptomatic infection | 4 (14.29) | 3 (8.33) |
 Mild illness | 4 (14.29) | 4 (11.11) |
 Moderate illness | 20 (71.43) | 24 (66.67) |
 Severe illness | 0 | 5 (13.89) |
Sampling intervals a –No. (%) | ||
  ≤ 7 d | 23 (85.2) | 9 (26.5) |
  > 7 d | 4 (14.8) | 25 (73.5) |
SARS-CoV-2 RNA detection (%) | ||
 Positive (+) | 28 (100) | 26 (72.22) |
 Negative (−) | 0 (0) | 10 (27.78) |